Skip to main content

Advertisement

SpringerLink
Log in

Long-term outcome of vertigo and dizziness associated disorders following treatment in specialized tertiary care: the Dizziness and Vertigo Registry (DiVeR) Study

  • Original Communication
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

To investigate the long-term outcome of interdisciplinary treatment in a tertiary care neuro-otology institution after 2 years as part of the Dizziness and Vertigo Registry study. Risk factors associated with unfavourable outcome were assessed. 3113 consecutive patients with disorders of vertigo and dizziness were recruited prospectively between March 2010 and February 2012. Patients were clinically assessed and treated according to their diagnosis. Standardized instruments were used at baseline and at 2-year follow-up [Dizziness Handicap Inventory (DHI), Quality of Life Questionnaire, General Depression Scale, Stait-Trait Anxiety Index], as well as a custom health-related questionnaire. The primary outcome variable of this observational study was the change in DHI after 2 years. Patients suffered from phobic postural vertigo (23 %), benign peripheral paroxysmal vertigo (14.4 %), unilateral vestibulopathy (10.5 %), central vestibular disorders (8 %), Menière’s disease (9.8 %), vestibular migraine (6.9 %), bilateral vestibulopathy (5.5 %), and vestibular paroxysmia (3.1 %). Mean disease duration was 4.6 ± 6.3 years. 1272 patients were available for follow-up, 1159 completed the DHI score. 72.1 % of patients improved in DHI score from baseline to 2 years follow-up. Mean reduction in DHI score was 14 points (p = 0.02). Long-term outcome following diagnosis and treatment in a specialized tertiary care centre is good and persistent after 2 years. Risk factors for an unfavourable outcome were advanced age, severe disability, constant vertigo or dizziness, and concomitant back pain, while depression and anxiety did not contribute to this risk considerably.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Hannaford PC, Simpson JA, Bisset AF, Davis A, McKerrow W, Mills R (2005) The prevalence of ear, nose and throat problems in the community: results from a national cross-sectional postal survey in Scotland. Fam Pract 22(3):227–233

    Article  PubMed  Google Scholar 

  2. Yardley L, Owen N, Nazareth I, Luxon L (1998) Prevalence and presentation of dizziness in a general practice community sample of working age people. Br J Gen Pract J R Coll Gen Pract 48(429):1131–1135

    CAS  Google Scholar 

  3. Kroenke K, Price RK (1993) Symptoms in the community. Prevalence, classification, and psychiatric comorbidity. Arch Intern Med 153(21):2474–2480

    Article  CAS  PubMed  Google Scholar 

  4. Neuhauser HK, von Brevern M, Radtke A, Lezius F, Feldmann M, Ziese T et al (2005) Epidemiology of vestibular vertigo: a neurotologic survey of the general population. Neurology 65(6):898–904

    Article  CAS  PubMed  Google Scholar 

  5. Sloane PD (1989) Dizziness in primary care. Results from the national ambulatory medical care survey. J Fam Pract 29(1):33–38

    CAS  PubMed  Google Scholar 

  6. Best C, Eckhardt-Henn A, Diener G, Bense S, Breuer P, Dieterich M (2006) Interaction of somatoform and vestibular disorders. J Neurol Neurosurg Psychiatry 77(5):658–664

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  7. Jacobson GP, Newman CW (1990) The development of the Dizziness Handicap Inventory. Arch Otolaryngol Head Neck Surg 116(4):424–427

    Article  CAS  PubMed  Google Scholar 

  8. Equilibrium CoHa (1995) Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Menière’s disease. Am Acad Otolaryngol Head Neck Found Inc Otolaryngol Head Neck Surg Off J Am Acad Otolaryngol Head Neck Surg 113(3):181–185

    Article  Google Scholar 

  9. Lempert T, Olesen J, Furman J, Waterston J, Seemungal B, Carey J et al (2012) Vestibular migraine: diagnostic criteria. J Vestib Res Equilib Orientat 22(4):167–172

    Google Scholar 

  10. Brandt T, Huppert D, Dieterich M (1994) Phobic postural vertigo: a first follow-up. J Neurol 241(4):191–195

    Article  CAS  PubMed  Google Scholar 

  11. Prokopakis E, Vlastos IM, Tsagournisakis M, Christodoulou P, Kawauchi H, Velegrakis G (2013) Canalith repositioning procedures among 965 patients with benign paroxysmal positional vertigo. Audiol Neurootol 18(2):83–88

    Article  CAS  PubMed  Google Scholar 

  12. Prokopakis EP, Chimona T, Tsagournisakis M, Christodoulou P, Hirsch BE, Lachanas VA et al (2005) Benign paroxysmal positional vertigo: 10-year experience in treating 592 patients with canalith repositioning procedure. Laryngoscope 115(9):1667–1671

    Article  PubMed  Google Scholar 

  13. Sekine K, Imai T, Sato G, Ito M, Takeda N (2006) Natural history of benign paroxysmal positional vertigo and efficacy of Epley and Lempert maneuvers. Otolaryngol Head Neck Surg Off J Am Acad Otolaryngol Head Neck Surg 135(4):529–533

    Article  Google Scholar 

  14. von Brevern M, Radtke A, Lezius F, Feldmann M, Ziese T, Lempert T et al (2007) Epidemiology of benign paroxysmal positional vertigo: a population based study. J Neurol Neurosurg Psychiatry 78(7):710–715

    Article  Google Scholar 

  15. Sato G, Sekine K, Matsuda K, Takeda N (2013) Risk factors for poor outcome of a single Epley maneuver and residual positional vertigo in patients with benign paroxysmal positional vertigo. Acta Otolaryngol 133(11):1124–1127

    Article  PubMed  Google Scholar 

  16. Tschan R, Best C, Wiltink J, Beutel ME, Dieterich M, Eckhardt-Henn A (2013) Persistence of symptoms in primary somatoform vertigo and dizziness: a disorder “lost” in health care? J Nerv Ment Dis 201(4):328–333

    Article  PubMed  Google Scholar 

  17. Holmberg J, Karlberg M, Harlacher U, Magnusson M (2007) One-year follow-up of cognitive behavioral therapy for phobic postural vertigo. J Neurol 254(9):1189–1192

    Article  PubMed  Google Scholar 

  18. Ruckenstein MJ, Staab JP (2009) Chronic subjective dizziness. Otolaryngol Clin N Am 42(1):71–77 (ix)

    Article  Google Scholar 

  19. Kaderli R, Seelandt J, Umer M, Tschan F, Businger A (2013) Reasons for the persistence of adverse events in the era of safer surgery—a qualitative approach. Swiss Med Wkly 143:w13882

    PubMed  Google Scholar 

  20. Strupp M, Hupert D, Frenzel C, Wagner J, Hahn A, Jahn K et al (2008) Long-term prophylactic treatment of attacks of vertigo in Menière’s disease—comparison of a high with a low dosage of betahistine in an open trial. Acta Otolaryngol 128(5):520–524

    Article  CAS  PubMed  Google Scholar 

  21. Ramsey RR, Ryan JL, Hershey AD, Powers SW, Aylward BS, Hommel KA (2014) Treatment adherence in patients with headache: a systematic review. Headache 54(5):795–816

    Article  PubMed  Google Scholar 

  22. Lempert T, Neuhauser H (2009) Epidemiology of vertigo, migraine and vestibular migraine. J Neurol 256(3):333–338

    Article  PubMed  Google Scholar 

  23. Best C, Eckhardt-Henn A, Tschan R, Dieterich M (2009) Psychiatric morbidity and comorbidity in different vestibular vertigo syndromes. Results of a prospective longitudinal study over one year. J Neurol 256(1):58–65

    Article  PubMed  Google Scholar 

  24. Yoon MS, Manack A, Schramm S, Fritsche G, Obermann M, Diener HC et al (2013) Chronic migraine and chronic tension-type headache are associated with concomitant low back pain: results of the German Headache Consortium study. Pain 154(3):484–492

    Article  PubMed  Google Scholar 

  25. Karatas M (2008) Central vertigo and dizziness: epidemiology, differential diagnosis, and common causes. Neurol 14(6):355–364

    Article  Google Scholar 

  26. Brown KE, Whitney SL, Marchetti GF, Wrisley DM, Furman JM (2006) Physical therapy for central vestibular dysfunction. Arch Phys Med Rehabil 87(1):76–81

    Article  PubMed  Google Scholar 

  27. Hillier SL, McDonnell M (2011) Vestibular rehabilitation for unilateral peripheral vestibular dysfunction. Cochrane Database Syst Rev (2):CD005397

  28. Zingler VC, Weintz E, Jahn K, Mike A, Huppert D, Rettinger N et al (2008) Follow-up of vestibular function in bilateral vestibulopathy. J Neurol Neurosurg Psychiatry 79(3):284–288

    Article  CAS  PubMed  Google Scholar 

  29. Gillespie MB, Minor LB (1999) Prognosis in bilateral vestibular hypofunction. Laryngoscope 109(1):35–41

    Article  CAS  PubMed  Google Scholar 

  30. Krebs DE, Gill-Body KM, Parker SW, Ramirez JV, Wernick-Robinson M (2003) Vestibular rehabilitation: useful but not universally so. Otolaryngol Head Neck Surg Off J Am Acad Otolaryngol Head Neck Surg 128(2):240–250

    Article  Google Scholar 

  31. Eleftheriadou A, Skalidi N, Velegrakis GA (2012) Vestibular rehabilitation strategies and factors that affect the outcome. Eur Arch Oto Rhino Laryngol Off J Eur Fed Oto Rhino Laryngol Soc 269(11):2309–2316

    Article  Google Scholar 

  32. Geser R, Straumann D (2012) Referral and final diagnoses of patients assessed in an academic vertigo center. Front Neurol 3:169

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Acknowledgement

We would like to thank Prof. Thomas Brandt for his valuable input, revision, and constructive criticism of this manuscript.

Conflicts of interest

Mark Obermann has received scientific support and/or honoraria from Biogen Idec, Novartis, Sanofi-Aventis, Genzyme, Pfizer, Teva and Heel. He received research grants from Allergan, Electrocore, Heel, and the German Ministry for Education and Research (BMBF). Eva Bock has nothing to disclose. Nikolay Sabev has nothing to disclose. Nils Lehmann has nothing to disclose. Ralph Weber received honoria for oral presentations from Boehringer Ingelheim. Bristol-Myers Squibb and Covidien. Marcus Gerwig has nothing to disclose. Markus Frings has nothing to disclose. Diana Arweiler-Harbeck has nothing to disclose. Stephan Lang has nothing to disclose. Hans-Christoph Diener has received honoraria for participation in clinical trials, contribution to advisory boards or lectures from Addex Pharma, Allergan, Almirall, AstraZeneca, Bayer Vital, Berlin Chemie, Coherex Medical, CoLucid, Böhringer Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, Grünenthal, Janssen-Cilag, Lilly, La Roche, 3 M Medica, Minster, MSD, Novartis, Johnson & Johnson, Pierre Fabre, Pfizer, Schaper and Brümmer, SanofiAventis, and Weber & Weber; received research support from Allergan, Almirall, AstraZeneca, Bayer, Galaxo-Smith-Kline, Janssen-Cilag, and Pfizer. Research at the Department of Neurology in Essen is supported by the German Research Council (DFG), the German Ministry of Education and Research (BMBF), and the European Union.

Author information

Authors and Affiliations

  1. Department of Neurology, University of Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Germany

    Mark Obermann, Nikolay Sabev, Marcus Gerwig, Markus Frings & Hans-Christoph Diener

  2. Institute for Medical Informatics Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany

    Eva Bock & Nils Lehmann

  3. Department of Otorhinolaryngology, University of Duisburg-Essen, Essen, Germany

    Diana Arweiler-Harbeck & Stephan Lang

  4. Department of Neurology, Alfried-Krupp-Hospital Essen, Essen, Germany

    Ralph Weber

  5. Center for Neurology, Asklepios Hospitals Schildautal, Seesen, Germany

    Mark Obermann

Authors
  1. Mark Obermann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eva Bock
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nikolay Sabev
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Nils Lehmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ralph Weber
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Marcus Gerwig
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Markus Frings
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Diana Arweiler-Harbeck
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Stephan Lang
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Hans-Christoph Diener
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mark Obermann.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 160 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Obermann, M., Bock, E., Sabev, N. et al. Long-term outcome of vertigo and dizziness associated disorders following treatment in specialized tertiary care: the Dizziness and Vertigo Registry (DiVeR) Study. J Neurol 262, 2083–2091 (2015). https://doi.org/10.1007/s00415-015-7803-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-015-7803-7

Keywords

Search

Navigation